title: C-peptide in the natural history of type 1 diabetes.
abstract: Type 1 diabetes is diagnosed when the patient's endogenous insulin secretion decreases to a level which results in hyperglycemia. After diagnosis, insulin secretion continues to decline. As a reference for clinical trials trying to preserve endogenous beta-cell function in patients with recently diagnosed type 1 diabetes, in this short review I attempt to summarize the natural history of endogenous beta-cell function after the diagnosis of type 1 diabetes.
authors.affiliation: Department of Medicine, Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, WA, USA. jpp@u.washington.edu
authors.forename: Jerry P
authors.initials: JP
authors.lastname: Palmer
mesh_terms: D002096:C-Peptide / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000378:metabolism / Q000503:physiopathology*; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000378:metabolism*
chemical_list: D002096:C-Peptide; D007328:Insulin